Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: Negotiations on the Acquisitions of Almost All Assets 12-Jun-2023 / 10:21 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. […]
Year: 2023
31. May 2023
Epigenomics AG Reports Financial Results for the First Quarter of 2023
EQS-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2023 31.05.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2023 Berlin (Germany) and San Diego, CA (USA), May 31, […]
19. May 2023
Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
EQS-News: Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns 19.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns Berlin (Germany), May 19, 2023 -The Member […]
19. May 2023
Epigenomics AG: Changes in the Management
Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Changes in the Management 19-May-2023 / 17:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics AG: Changes in […]
28. April 2023
Epigenomics AG publishes financial results for fiscal year 2022
EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual ReportEpigenomics AG publishes financial results for fiscal year 2022 28.04.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2022 Berlin (Germany) and San Diego, CA (U.S.A.), April 28, 2023 – Epigenomics AG (FSE: ECX, […]
26. April 2023
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG / Total Voting Rights Announcement Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 26.04.2023 / 11:46 CET/CEST Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content […]